Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer
In Vivo · 2025
DOI: 10.21873/invivo.13909 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Hung-Ming Chiu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: The present study explored the use of Waikato Environment for Knowledge Analysis (WEKA) to analyze hematological parameters for distinguishing potential development and progression of cervical cancer. Specifically, we aimed to identify significant biomarkers capable of differentiating atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesions (LSIL) from cervical cancer-negative and advanced conditions such as cervical adenocarcinoma. MATERIALS AND METHODS: Hematological and biochemical data were collected from patients and analyzed using data-mining algorithms available in WEKA. The random forest algorithm was employed to identify patterns among key hematological and biochemical biomarkers, alongside one-way analysis of variance to determine significant alterations in these parameters across cancer-negative, ASC-US, LSIL and adenocarcinoma groups. RESULTS: Random forest was the classifier model that demonstrated superior performance metrics with high recall (1.000) and accuracy (0.843), Matthews correlation coefficient (0.510) and area under the curve (0.708), effectively identifying significant patterns within the datasets. One-way analysis of variance indicated significant alterations in red and white blood cell counts, platelet count, hemoglobin, hematocrit and other white blood cell parameters between cancer-negative, ASC-US, LSIL and adenocarcinoma, emphasizing the role of hematological parameters in identifying progression risk. CONCLUSION: The consistency in conclusions drawn from data mining and statistical analyses highlight the utility of hematological parameters as potential non-invasive biomarkers for cervical cancer screening and progression monitoring. These findings suggest that integrating machine-learning algorithms, particularly random forest, with hematological analysis might enhance early diagnosis and improve clinical outcomes for patients with cervical abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan, R.O.C.
- Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
- Doctoral Program in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan, R.O.C.; ywchu@nchu.edu.tw.
- Graduate Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan, R.O.C.
- Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan, R.O.C.
- Smart Sustainable New Agriculture Research Center (SMARTer), Taichung, Taiwan, R.O.C.
Zitieren
APA
Chiu, H. M., Lin, S. E., Chu, Y. W., & Chen, C. J. (2025). Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer. In Vivo. https://doi.org/10.21873/invivo.13909
Vancouver
Chiu HM, Lin SE, Chu YW, Chen CJ. Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer. In Vivo. 2025. doi:10.21873/invivo.13909
BibTeX
@article{Chiu2025,
author = {Chiu, Hung-Ming and Lin, Shih-En and Chu, Yen-Wei and Chen, Chih-Jung},
title = {Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13909}
}
EUVIMED